Ghaziabad, India

Moloy Mitra

This inventor holds 1 USPTO granted patent. Top assignee: Fresenius Kabi Oncology Limited. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Moloy Mitra. Retrieved from https://idiyas.com/inventor/moloy-mitra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Moloy Mitra

Introduction

Moloy Mitra is a notable inventor based in Ghaziabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new forms of existing medications. His work focuses on improving the bioavailability and effectiveness of therapeutic agents.

Latest Patents

Mitra holds a patent for Metaxalone polymorphs, which includes two crystalline forms, A and B, of the skeletal muscle relaxant and anxiolytic agent, Metaxalone. This invention provides a process for the preparation of these forms, which are bioavailable. The pharmaceutical compositions derived from these crystalline forms are designed to relieve discomfort associated with acute, painful musculoskeletal conditions.

Career Highlights

Moloy Mitra is currently employed at Fresenius Kabi Oncology Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the development of effective treatments for various medical conditions.

Collaborations

Mitra collaborates with talented professionals in his field, including Subrata Sarkar and Jyan Shankar Mahanty. These partnerships enhance the research and development efforts at Fresenius Kabi Oncology Limited.

Conclusion

Moloy Mitra's contributions to the pharmaceutical industry, particularly through his patent on Metaxalone polymorphs, highlight his role as an innovative inventor. His work not only advances medical science but also improves patient care through more effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…